Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Compugen (CGEN)

Compugen Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGEN
DateTimeSourceHeadlineSymbolCompany
13/12/201111:15Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
13/12/201111:00Business WireBioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by CompugenNASDAQ:CGENCompugen Ltd
30/11/201112:06Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
30/11/201112:00Business WireCompugen Presents Predictive Drug Target Discovery Platform at European Antibody ConferenceNASDAQ:CGENCompugen Ltd
29/11/201112:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
29/11/201112:00Business WireCompugen and DiscoveRx® Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug TargetsNASDAQ:CGENCompugen Ltd
08/11/201112:02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
08/11/201112:00Business WireCompugen Reports Third Quarter 2011 Financial ResultsNASDAQ:CGENCompugen Ltd
25/10/201112:03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
25/10/201112:00Business WireCompugen's CGEN-15001 Pre-Clinical Data Presented at International Conference on Immune ToleranceNASDAQ:CGENCompugen Ltd
24/10/201112:00Business WireCompugen Third Quarter 2011 Conference Call Scheduled for Tuesday, November 8, 2011 at 10:00 AM ESTNASDAQ:CGENCompugen Ltd
12/10/201113:03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
12/10/201113:00Business WirePulmonary Fibrosis Foundation to Fund Further Therapeutic Evaluation Studies for Compugen-Discovered Drug CandidateNASDAQ:CGENCompugen Ltd
13/09/201112:02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
13/09/201112:00Business WireCompugen Announces Validation of Two Immune System Modulating Drug CandidatesNASDAQ:CGENCompugen Ltd
01/09/201121:06Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:CGENCompugen Ltd
02/08/201112:02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
02/08/201112:00Business WireCompugen Reports Second Quarter 2011 Financial ResultsNASDAQ:CGENCompugen Ltd
27/07/201112:01Business WireCompugen Second Quarter 2011 Conference Call Scheduled for Tuesday, August 2, 2011 at 10:00 AM EDTNASDAQ:CGENCompugen Ltd
21/06/201113:06Business WireCompugen Announces Initial Validation of Additional B7/CD28 Protein Family Based Product CandidateNASDAQ:CGENCompugen Ltd
21/06/201113:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
19/05/201112:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
19/05/201112:00Business WireCompugen Discloses Discovery Method for Drug Candidates That Interfere With Protein ConformationsNASDAQ:CGENCompugen Ltd
11/05/201112:46Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
11/05/201112:45Business WireCompugen Reports First Quarter 2011 Financial ResultsNASDAQ:CGENCompugen Ltd
05/05/201116:10Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
03/05/201114:00Business WireCompugen First Quarter 2011 Webcast and Conference Call Scheduled for Wednesday, May 11, 2011 at 10:00 AM EDTNASDAQ:CGENCompugen Ltd
29/04/201119:35Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
27/04/201112:00Business WireCompugen Discloses Splice Variant Based Program to Discover Superior Oncology Drug Targets for mAb TherapyNASDAQ:CGENCompugen Ltd
27/04/201111:43Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Your Recent History

Delayed Upgrade Clock